Drug Research, Reimagined

Summary

I helped design a neuroscience research platform that enables biomedical engineers to model, simulate, and validate psychiatric drug experiments using AI-driven methods and real patient data.

Problem

How might we simplify and accelerate the creation of complex psychiatric drug experiments — and enable scientists to test ideas faster and with greater accuracy?

Role & Team

As a Product Designer on the core product pod, I led UX, visual and interaction design. I collaborated with an illustrator to shape both the interface and the broader design system.

Approach

We took a linear research-heavy approach, starting with deep discovery work through expert interviews with neuroscientists and biomedical engineers. Stakeholder alignment sessions were held to define critical workflows. Iterative testing was done to ensure scientific accuracy and usability.

Challenges

The domain complexity of psychopharmacology was immense — requiring rapid upskilling and cross-functional collaboration. No direct competitors or reference products existed, so all interaction models were built from scratch. We faced time pressure to demo a working version at an upcoming neuroscience conference.

Solution

We designed a node-based interface that allows researchers to build, visualize, and simulate psychiatric drug experiments. It helps integrate AI models with real patient data. Users can run repeatable simulations to validate results without requiring physical lab work.

strategy hub
strategy hub
strategy hub
strategy hub
strategy hub
Impact

Helped company gain credibility towards Series C funding from conference demo's.

Next Steps

To expand the platform into a full research suite for psychiatric scientists. To improve simulation accuracy and UI flexibility for more complex experiment types.

Bonus

I took up the development of a brand strategy to help competitive positioning of the company in the marketplace.

see branding

Linkedin
Contact me

This website contains forward-looking statements within the meaning of applicable securities laws. These statements reflect the current expectations, estimates, and projections by the designer regarding future business activities, financial performance, industry trends, and market opportunities. Forward-looking statements may include, but are not limited to, expectations regarding product development, regulatory approvals, technological advancements, customer demand, and future financial and operational results. Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “will,” and similar expressions are intended to identify forward-looking statements. These statements are based on current assumptions and are subject to inherent risks and uncertainties, many of which are beyond the designer's control. Actual results may differ materially due to various factors, including but not limited to changes in market conditions, regulatory developments, technological shifts, competitive pressures, supply chain disruptions, and macroeconomic factors. The designer undertakes no obligation to publicly update or revise any forward-looking statement, except as required by law. Investors and stakeholders are cautioned not to place undue reliance on these statements, as they involve inherent risks and uncertainties that could materially affect future results. For further details on potential risks and uncertainties, please refer to my latest disclosures, and risk assessments.